A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE PROTECTIVE EFFICACY OF ORALLY DELIVERED BOVINE SERUM IMMUNOGLOBULIN (BSIGG) SPECIFIC FOR THE COLONIZATION FACTOR CS6 FOLLOWING CHALLENGE WITH THE CS6-EXPRESSING ENTEROTOXIGENIC E-COLI (ETEC) STRAIN B7A